Literature DB >> 4375789

In vitro effect of metronidazole and tinidazole on anaerobic bacteria.

K Dornbusch, C E Nord.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4375789     DOI： 10.1007/bf02121441

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  6 in total

1.  Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration.

Authors:  P O KANE; J A McFADZEAN; S SQUIRES; A J KING; C S NICOL
Journal:  Br J Vener Dis       Date:  1961-12

2.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

3.  Single and low dosage regimens of metronidazole in amoebic dysentery and amoebic liver abscess.

Authors:  S J Powell; A J Wilmot; R Elsdon-Dew
Journal:  Ann Trop Med Parasitol       Date:  1969-06

4.  Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.

Authors:  L J Nastro; S M Finegold
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

5.  Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa.

Authors:  H L Howes; J E Lynch; J L Kivlin
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

6.  Bactericidal activity of metronidazole against Bacteroides fragilis.

Authors:  J P Whelan; J H Hale
Journal:  J Clin Pathol       Date:  1973-06       Impact factor: 3.411
  6 in total
  15 in total

1.  Penetration of tinidazole into skin blister fluid following its oral administration.

Authors:  A Klimowicz; A Nowak; S Bielecka-Grzela
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

3.  Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.

Authors:  A M Jokipii; L Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

4.  Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.

Authors:  J Wust
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

5.  Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.

Authors:  A Krook; B Lindström; J Kjellander; G Järnerot; L Bodin
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

6.  Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.

Authors:  B L Flouvat; C Imbert; D M Dubois; B P Temperville; A F Roux; G C Chevalier; G Humbert
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

7.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

8.  Liquid chromatographic assay for metronidazole and tinidazole: pharmacokinetic and metabolic studies in human subjects.

Authors:  I Nilsson-Ehle; B Ursing; P Nilsson-Ehle
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

9.  Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.

Authors:  L Dubreuil; J Devos; C Neut; C Romond
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

Review 10.  Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-08       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.